WASHINGTON, Oct. 2 -- National Institutes of Health has issued a notice called: Government Owned Inventions Available for Licensing and/or Collaboration: Automated Cell Radiolabeling Device Using Acoustophoresis Micro-Fluidic Technology.

The notice was published in the Federal Register on Oct. 2 by Richard U. Rodriguez, Associate Director, Technology Transfer Center. National Cancer Institute.

Summary: The National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), Department of Health and Human Services (HHS), seeks research co-development partners and/or licensees for an automated acoustophoresis device to radio-label and isolate cells. This invention is owned by an agency of the U.S. Government and is avai...